Copyright Reports & Markets. All rights reserved.

Global Medical Transdermal Drug Delivery System Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Medical Transdermal Drug Delivery System Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Fentanyl
    • 1.3.3 Nitroglycerin
    • 1.3.4 Estradiol
    • 1.3.5 Nicotine
    • 1.3.6 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Medical Transdermal Drug Delivery System Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Prescription Drugs
    • 1.4.3 Non-prescription Drugs
  • 1.5 Global Medical Transdermal Drug Delivery System Market Size & Forecast
    • 1.5.1 Global Medical Transdermal Drug Delivery System Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Medical Transdermal Drug Delivery System Sales Quantity (2021-2032)
    • 1.5.3 Global Medical Transdermal Drug Delivery System Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 3M
    • 2.1.1 3M Details
    • 2.1.2 3M Major Business
    • 2.1.3 3M Medical Transdermal Drug Delivery System Product and Services
    • 2.1.4 3M Medical Transdermal Drug Delivery System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 3M Recent Developments/Updates
  • 2.2 Hisamitsu
    • 2.2.1 Hisamitsu Details
    • 2.2.2 Hisamitsu Major Business
    • 2.2.3 Hisamitsu Medical Transdermal Drug Delivery System Product and Services
    • 2.2.4 Hisamitsu Medical Transdermal Drug Delivery System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Hisamitsu Recent Developments/Updates
  • 2.3 Mylan
    • 2.3.1 Mylan Details
    • 2.3.2 Mylan Major Business
    • 2.3.3 Mylan Medical Transdermal Drug Delivery System Product and Services
    • 2.3.4 Mylan Medical Transdermal Drug Delivery System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Mylan Recent Developments/Updates
  • 2.4 GSK
    • 2.4.1 GSK Details
    • 2.4.2 GSK Major Business
    • 2.4.3 GSK Medical Transdermal Drug Delivery System Product and Services
    • 2.4.4 GSK Medical Transdermal Drug Delivery System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 GSK Recent Developments/Updates
  • 2.5 Novartis
    • 2.5.1 Novartis Details
    • 2.5.2 Novartis Major Business
    • 2.5.3 Novartis Medical Transdermal Drug Delivery System Product and Services
    • 2.5.4 Novartis Medical Transdermal Drug Delivery System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Novartis Recent Developments/Updates
  • 2.6 Teve (Actavis)
    • 2.6.1 Teve (Actavis) Details
    • 2.6.2 Teve (Actavis) Major Business
    • 2.6.3 Teve (Actavis) Medical Transdermal Drug Delivery System Product and Services
    • 2.6.4 Teve (Actavis) Medical Transdermal Drug Delivery System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Teve (Actavis) Recent Developments/Updates
  • 2.7 Johnson & Johnson
    • 2.7.1 Johnson & Johnson Details
    • 2.7.2 Johnson & Johnson Major Business
    • 2.7.3 Johnson & Johnson Medical Transdermal Drug Delivery System Product and Services
    • 2.7.4 Johnson & Johnson Medical Transdermal Drug Delivery System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Johnson & Johnson Recent Developments/Updates
  • 2.8 Lohmann
    • 2.8.1 Lohmann Details
    • 2.8.2 Lohmann Major Business
    • 2.8.3 Lohmann Medical Transdermal Drug Delivery System Product and Services
    • 2.8.4 Lohmann Medical Transdermal Drug Delivery System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Lohmann Recent Developments/Updates
  • 2.9 Teikoku Seiyaku
    • 2.9.1 Teikoku Seiyaku Details
    • 2.9.2 Teikoku Seiyaku Major Business
    • 2.9.3 Teikoku Seiyaku Medical Transdermal Drug Delivery System Product and Services
    • 2.9.4 Teikoku Seiyaku Medical Transdermal Drug Delivery System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Teikoku Seiyaku Recent Developments/Updates
  • 2.10 Bayer
    • 2.10.1 Bayer Details
    • 2.10.2 Bayer Major Business
    • 2.10.3 Bayer Medical Transdermal Drug Delivery System Product and Services
    • 2.10.4 Bayer Medical Transdermal Drug Delivery System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Bayer Recent Developments/Updates
  • 2.11 Lingrui
    • 2.11.1 Lingrui Details
    • 2.11.2 Lingrui Major Business
    • 2.11.3 Lingrui Medical Transdermal Drug Delivery System Product and Services
    • 2.11.4 Lingrui Medical Transdermal Drug Delivery System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Lingrui Recent Developments/Updates
  • 2.12 Sanofi
    • 2.12.1 Sanofi Details
    • 2.12.2 Sanofi Major Business
    • 2.12.3 Sanofi Medical Transdermal Drug Delivery System Product and Services
    • 2.12.4 Sanofi Medical Transdermal Drug Delivery System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Sanofi Recent Developments/Updates
  • 2.13 Qizheng
    • 2.13.1 Qizheng Details
    • 2.13.2 Qizheng Major Business
    • 2.13.3 Qizheng Medical Transdermal Drug Delivery System Product and Services
    • 2.13.4 Qizheng Medical Transdermal Drug Delivery System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Qizheng Recent Developments/Updates
  • 2.14 Endo
    • 2.14.1 Endo Details
    • 2.14.2 Endo Major Business
    • 2.14.3 Endo Medical Transdermal Drug Delivery System Product and Services
    • 2.14.4 Endo Medical Transdermal Drug Delivery System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Endo Recent Developments/Updates
  • 2.15 Laboratoires Genevrier
    • 2.15.1 Laboratoires Genevrier Details
    • 2.15.2 Laboratoires Genevrier Major Business
    • 2.15.3 Laboratoires Genevrier Medical Transdermal Drug Delivery System Product and Services
    • 2.15.4 Laboratoires Genevrier Medical Transdermal Drug Delivery System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 Laboratoires Genevrier Recent Developments/Updates
  • 2.16 Haw Par
    • 2.16.1 Haw Par Details
    • 2.16.2 Haw Par Major Business
    • 2.16.3 Haw Par Medical Transdermal Drug Delivery System Product and Services
    • 2.16.4 Haw Par Medical Transdermal Drug Delivery System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.16.5 Haw Par Recent Developments/Updates
  • 2.17 Nichiban
    • 2.17.1 Nichiban Details
    • 2.17.2 Nichiban Major Business
    • 2.17.3 Nichiban Medical Transdermal Drug Delivery System Product and Services
    • 2.17.4 Nichiban Medical Transdermal Drug Delivery System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.17.5 Nichiban Recent Developments/Updates
  • 2.18 Mentholatum
    • 2.18.1 Mentholatum Details
    • 2.18.2 Mentholatum Major Business
    • 2.18.3 Mentholatum Medical Transdermal Drug Delivery System Product and Services
    • 2.18.4 Mentholatum Medical Transdermal Drug Delivery System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.18.5 Mentholatum Recent Developments/Updates

3 Competitive Environment: Medical Transdermal Drug Delivery System by Manufacturer

  • 3.1 Global Medical Transdermal Drug Delivery System Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Medical Transdermal Drug Delivery System Revenue by Manufacturer (2021-2026)
  • 3.3 Global Medical Transdermal Drug Delivery System Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Medical Transdermal Drug Delivery System by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Medical Transdermal Drug Delivery System Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Medical Transdermal Drug Delivery System Manufacturer Market Share in 2025
  • 3.5 Medical Transdermal Drug Delivery System Market: Overall Company Footprint Analysis
    • 3.5.1 Medical Transdermal Drug Delivery System Market: Region Footprint
    • 3.5.2 Medical Transdermal Drug Delivery System Market: Company Product Type Footprint
    • 3.5.3 Medical Transdermal Drug Delivery System Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Medical Transdermal Drug Delivery System Market Size by Region
    • 4.1.1 Global Medical Transdermal Drug Delivery System Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Medical Transdermal Drug Delivery System Consumption Value by Region (2021-2032)
    • 4.1.3 Global Medical Transdermal Drug Delivery System Average Price by Region (2021-2032)
  • 4.2 North America Medical Transdermal Drug Delivery System Consumption Value (2021-2032)
  • 4.3 Europe Medical Transdermal Drug Delivery System Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Medical Transdermal Drug Delivery System Consumption Value (2021-2032)
  • 4.5 South America Medical Transdermal Drug Delivery System Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Medical Transdermal Drug Delivery System Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Medical Transdermal Drug Delivery System Sales Quantity by Type (2021-2032)
  • 5.2 Global Medical Transdermal Drug Delivery System Consumption Value by Type (2021-2032)
  • 5.3 Global Medical Transdermal Drug Delivery System Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Medical Transdermal Drug Delivery System Sales Quantity by Application (2021-2032)
  • 6.2 Global Medical Transdermal Drug Delivery System Consumption Value by Application (2021-2032)
  • 6.3 Global Medical Transdermal Drug Delivery System Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Medical Transdermal Drug Delivery System Sales Quantity by Type (2021-2032)
  • 7.2 North America Medical Transdermal Drug Delivery System Sales Quantity by Application (2021-2032)
  • 7.3 North America Medical Transdermal Drug Delivery System Market Size by Country
    • 7.3.1 North America Medical Transdermal Drug Delivery System Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Medical Transdermal Drug Delivery System Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Medical Transdermal Drug Delivery System Sales Quantity by Type (2021-2032)
  • 8.2 Europe Medical Transdermal Drug Delivery System Sales Quantity by Application (2021-2032)
  • 8.3 Europe Medical Transdermal Drug Delivery System Market Size by Country
    • 8.3.1 Europe Medical Transdermal Drug Delivery System Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Medical Transdermal Drug Delivery System Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Medical Transdermal Drug Delivery System Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Medical Transdermal Drug Delivery System Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Medical Transdermal Drug Delivery System Market Size by Region
    • 9.3.1 Asia-Pacific Medical Transdermal Drug Delivery System Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Medical Transdermal Drug Delivery System Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Medical Transdermal Drug Delivery System Sales Quantity by Type (2021-2032)
  • 10.2 South America Medical Transdermal Drug Delivery System Sales Quantity by Application (2021-2032)
  • 10.3 South America Medical Transdermal Drug Delivery System Market Size by Country
    • 10.3.1 South America Medical Transdermal Drug Delivery System Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Medical Transdermal Drug Delivery System Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Medical Transdermal Drug Delivery System Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Medical Transdermal Drug Delivery System Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Medical Transdermal Drug Delivery System Market Size by Country
    • 11.3.1 Middle East & Africa Medical Transdermal Drug Delivery System Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Medical Transdermal Drug Delivery System Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Medical Transdermal Drug Delivery System Market Drivers
  • 12.2 Medical Transdermal Drug Delivery System Market Restraints
  • 12.3 Medical Transdermal Drug Delivery System Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Medical Transdermal Drug Delivery System and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Medical Transdermal Drug Delivery System
  • 13.3 Medical Transdermal Drug Delivery System Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Medical Transdermal Drug Delivery System Typical Distributors
  • 14.3 Medical Transdermal Drug Delivery System Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Medical Transdermal Drug Delivery System market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    A transdermal drug delivery system (TTS), or transdermal patch, is a way for drugs to be absorbed into the body through the skin. TTS is a very useful form of drug delivery with many advantages. One is that when the patch is attached to the skin, drug administration can be visually confirmed. Additionally, these formulations are designed to control the rate of drug absorption, helping to maintain blood levels over a longer period of time.
    This report is a detailed and comprehensive analysis for global Medical Transdermal Drug Delivery System market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Medical Transdermal Drug Delivery System market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Medical Transdermal Drug Delivery System market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Medical Transdermal Drug Delivery System market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Medical Transdermal Drug Delivery System market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Medical Transdermal Drug Delivery System
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Medical Transdermal Drug Delivery System market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include 3M, Hisamitsu, Mylan, GSK, Novartis, Teve (Actavis), Johnson & Johnson, Lohmann, Teikoku Seiyaku, Bayer, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Medical Transdermal Drug Delivery System market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Fentanyl
    Nitroglycerin
    Estradiol
    Nicotine
    Others
    Market segment by Application
    Prescription Drugs
    Non-prescription Drugs
    Major players covered
    3M
    Hisamitsu
    Mylan
    GSK
    Novartis
    Teve (Actavis)
    Johnson & Johnson
    Lohmann
    Teikoku Seiyaku
    Bayer
    Lingrui
    Sanofi
    Qizheng
    Endo
    Laboratoires Genevrier
    Haw Par
    Nichiban
    Mentholatum
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Medical Transdermal Drug Delivery System product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Medical Transdermal Drug Delivery System, with price, sales quantity, revenue, and global market share of Medical Transdermal Drug Delivery System from 2021 to 2026.
    Chapter 3, the Medical Transdermal Drug Delivery System competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Medical Transdermal Drug Delivery System breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Medical Transdermal Drug Delivery System market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Medical Transdermal Drug Delivery System.
    Chapter 14 and 15, to describe Medical Transdermal Drug Delivery System sales channel, distributors, customers, research findings and conclusion.

    Buy now